Last reviewed · How we verify
NCT04713943: IRON-SI
Efficacy of >Your< Iron Syrup Supplementation in Children With Dietary Iron Deficiency
NA trial testing >Your< Iron Syrup in Iron-deficiency in 94 participants. Completed in 22 June 2020.
22 June 2020
Quick facts
| Lead sponsor | PharmaLinea Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 94 |
| Start date | 22 December 2017 |
| Primary completion | 22 June 2020 |
| Estimated completion | 22 June 2020 |
| Sites | 15 locations across Slovenia |
Drugs / interventions tested
- >Your< Iron Syrup
- Placebo
Conditions studied
- Iron-deficiency — all drugs for Iron-deficiency →
Sponsor
PharmaLinea Ltd. — full company profile →
Who can join
Adults 9 Months to 6, any sex, with Iron-deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study evaluates the efficacy and safety of \>Your\< Iron Syrup, a novel iron-containing dietary supplement, in the management of dietary iron deficiency in children. The study is a randomized, double-blind, placebo-controlled intervention conducted in 16 research centers in Slovenia, collectively enrolling 92 eligible children. Eligibility of children for participation in the study will be determined by screening for hemoglobin and ferritin (combined with C-reactive protein) levels in a sample of capillary blood. Eligible children will receive basic dietary advice on how to increase the consumption of dietary iron and will be invited to participate in the study. Enrolled children will be randomized to either \>Your\< Iron Syrup arm or to placebo arm in a 3:1 ratio, respectively. Changes in body iron stores (ferritin) and in hematological indices as well as occurence of any adverse events will be monitored after 4 and 12 weeks of once-daily supplementation with either \>Your\< Iron Syrup or placebo.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Micronized, Microencapsulated Ferric Iron Supplementation in the Form of >Your< Iron Syrup Improves Hemoglobin and Ferritin Levels in Iron-Deficient Children: Double-Blind, Randomized Clinical Study of Efficacy and Safety.
Zečkanović A, Kavčič M, Prelog T, Šmid A, et al · · 2021 · cited 5× · PMID 33810451 · DOI 10.3390/nu13041087
Verify or expand the search:
- PubMed search for NCT04713943
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Iron-deficiency
Currently open trials in the same condition.
- NCT05407987 — Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) · Phase 3 · recruiting
- NCT06270498 — Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure · Phase 4 · recruiting
- NCT05913414 — Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma · Phase 2 · recruiting
- NCT05340465 — Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants · Phase 2 · recruiting
- NCT07083492 — Non-invasive Detection of Iron Deficiency in Obstetrics · recruiting
Other PharmaLinea Ltd. trials
Trials by the same sponsor.
- NCT05185024 — Daily Oral Iron Supplementation for Replenishment of Depleted Iron in Adults · NA · completed
- NCT05945667 — Efficacy and Safety of Uronext® in Women With Cystitis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04713943 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by PharmaLinea Ltd.
- Last refreshed: 20 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04713943.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing